Page last updated: 2024-08-25

efaroxan and rasagiline

efaroxan has been researched along with rasagiline in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amit, T; Angel, I; Bar-Am, O; Barac, YD; Binah, O; Frolov, L; Liani, E; Ovcharenko, E; Youdim, MB	1

Other Studies

1 other study(ies) available for efaroxan and rasagiline

Article	Year
I1 imidazoline receptor: novel potential cytoprotective target of TVP1022, the S-enantiomer of rasagiline. PloS one, 2012, Volume: 7, Issue:11 Topics: Animals; Benzofurans; Binding Sites; Blotting, Western; Cardiotonic Agents; Dose-Response Relationship, Drug; Imidazoles; Imidazoline Receptors; In Vitro Techniques; Indans; Inhibitory Concentration 50; Mitogen-Activated Protein Kinase 1; Myocytes, Cardiac; PC12 Cells; Rats; Signal Transduction	2012

Article

Year

I1 imidazoline receptor: novel potential cytoprotective target of TVP1022, the S-enantiomer of rasagiline.

PloS one, 2012, Volume: 7, Issue:11

Topics: Animals; Benzofurans; Binding Sites; Blotting, Western; Cardiotonic Agents; Dose-Response Relationship, Drug; Imidazoles; Imidazoline Receptors; In Vitro Techniques; Indans; Inhibitory Concentration 50; Mitogen-Activated Protein Kinase 1; Myocytes, Cardiac; PC12 Cells; Rats; Signal Transduction

2012